Short Interest in Ion Beam Applications SA (OTCMKTS:IOBCF) Increases By 129.9%

Ion Beam Applications SA (OTCMKTS:IOBCF) saw a significant increase in short interest in January. As of January 30th, there was short interest totaling 2,138 shares, an increase of 129.9% from the January 15th total of 930 shares. Based on an average daily volume of 414 shares, the days-to-cover ratio is presently 5.2 days. Based on an average daily volume of 414 shares, the days-to-cover ratio is presently 5.2 days.

Ion Beam Applications Stock Performance

OTCMKTS IOBCF remained flat at $18.15 during trading hours on Thursday. Ion Beam Applications has a 12-month low of $10.15 and a 12-month high of $19.00. The stock’s fifty day moving average is $15.46 and its 200 day moving average is $14.43.

About Ion Beam Applications

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.